Soligenix, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SNGX research report →
About the company
Soligenix, Inc. , a biopharmaceutical firm in its advanced development stages, concentrates on bringing innovative products to market within the United States, specifically targeting rare illnesses. The company's operations are divided into two main divisions: Specialized BioTherapeutics and Public Health Solutions.
- CEO
- Christopher J. Schaber
- IPO
- 1994
- Employees
- 14
- HQ
- Princeton, NJ, US
Price Chart
- Market Cap
- $3.99M
- P/E
- -0.20
- P/S
- 0.00
- P/B
- 1.27
- EV/EBITDA
- 0.15
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -246.04%
- ROIC
- -327.03%
- Revenue
- $0 · 0.00%
- Net Income
- $-11,080,380 · -34.04%
- EPS
- $-2.14 · 57.03%
- Op Income
- $-11,845,476
- FCF YoY
- -22.17%
- 52W High
- $6.23
- 52W Low
- $0.28
- 50D MA
- $0.52
- 200D MA
- $1.17
- Beta
- 1.92
- Avg Volume
- 7.55M
Get TickerSpark's AI analysis on SNGX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 11, 25 | Straube Richard | other | 10,000 |
| Dec 11, 25 | Donini Oreola | other | 100,000 |
| Dec 11, 25 | Guarino Jonathan L. | other | 100,000 |
| Dec 11, 25 | SCHABER CHRISTOPHER J | other | 200,000 |
| Oct 2, 25 | SCHABER CHRISTOPHER J | buy | 15,132 |
| Jun 20, 25 | LAPOINTE ANTHONY GREGG | other | 17,647 |
| Jun 20, 25 | ZELDIS JEROME B | other | 17,647 |
| Jun 20, 25 | RUBIN ROBERT J. | other | 17,647 |
| Jun 20, 25 | Parks Diane L. | other | 17,647 |
| Dec 12, 24 | Parks Diane L. | other | 8,646 |
Our SNGX coverage
Recent articles, reports, and earnings notes.
No research on SNGX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SNGX report →Similar companies
Peers in the same neighborhood.